Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

NCT01007019 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: YH4808 30mg
DRUG: YH4808 50mg
DRUG: YH4808 100mg
DRUG: YH4808 200mg
DRUG: YH4808
DRUG: YH4808 100mg (repeat dose)
DRUG: YH4808 200mg (repeat dose)
DRUG: YH4808 600mg
DRUG: YH4808 800mg (single dose)
DRUG: YH4808 400 mg (repeat doses)
DRUG: Placebo
DRUG: Esomeprazole 40mg

Sponsor

Yuhan Corporation